Noventra Pharma Retatrutide Research Compound peptide Pen 32mg
Weight Management • Appetite Control • Metabolic Support
Noventra Pharma Retatrutide 32mg is a pre-filled research peptide pen designed for precision dosing, stability, and ease of use in controlled laboratory environments. This format is developed to support consistent handling and repeatable administration protocols within advanced research workflows.
Retatrutide is a triple receptor agonist compound associated with GLP-1, GIP, and glucagon receptor activity and is commonly studied in metabolic research involving energy regulation, glucose pathways, appetite control, and overall metabolic function. The pen system offers a convenient and accurate delivery format for structured research applications requiring reliability and consistency.
Key Benefits
- Triple receptor agonist (GLP-1, GIP, and glucagon) commonly researched in metabolic studies
- May support appetite regulation and satiety-related research models
- Frequently explored in energy balance and glucose metabolism research contexts
- Pre-filled 32mg pen format for precision, convenience, and ease of use
- Designed for consistent, controlled, and repeatable delivery in research applications
- Long-acting peptide profile suitable for extended experimental protocols
- Stable compounded formulation intended for reliable handling and storage
- Suitable for advanced laboratory and metabolic research workflows.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
